Definitive Contract 75A50122C00057
- Not listed
- This $5,410,602.21 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a manufacturer of biological agent identification products and diagnostic solutions. The contract has an ultimate completion date of December 18, 2026 and does not utilize a set-aside designation. The contract requires Biofire Defense to provide all necessary services, personnel, material, equipment, and facilities to add the Biofire...
- This $30,788.88 firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer within the Department of Health and Human Services to Biofire Defense LLC, a manufacturer of biological agent identification products including the Biofire FilmArray and RAZOR Mk II systems. The contract supports biodefense and infectious disease diagnostics, with no set-aside designation. Biofire Defense has previously supported the Department of Defense, Department of State, National...
- This is a $20,997,823.75 cost-plus-fixed-fee contract awarded to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is funded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) and aims to advance the development of the BioFire Emerging Flu Panel, a nucleic acid detection panel for use on the BioFire FilmArray Torch and BioFire Spotfire platforms. This contract is not set aside for any specific business type. The...
- This contract was awarded by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $480,000.00 firm fixed price contract provides reagents and instruments such as a pneumonia verification kit, respiratory panel, and blood culture identification panel. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro...
- This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods. The $48,748.00 firm fixed price purchase order is for the delivery of a Respiratory Panel 2.1 IVD with 30 tests. The contract has an ultimate completion date of March 11, 2025. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems,...
- This is a $9,332,740.00 firm fixed price federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biofire Defense LLC for the advanced development of multiplex diagnostic platforms for infectious diseases. The contract has an ultimate completion date of April 12, 2022 and does not have a set-aside designation. Biofire Defense LLC is a for-profit limited liability company that provides...
- Biofire Defense, LLC has been awarded a firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health Clinical Center for $20,316. The award is for the delivery of biological agent identification products to support infectious disease diagnostics. No set-aside designation was used for this procurement. Biofire Defense is a manufacturer of fully integrated suites for biological threat detection, including the Biofire FilmArray and RAZOR Mk II...
- The U.S. government has awarded a delivery order contract worth $69,670 to Biofire Defense LLC, a for-profit limited liability company, for the "Development, Production and Maintenance Services for the Next Generation Diagnostics System 1." This order is part of a larger indefinite delivery contract awarded to Biofire Defense by the Army's Acquisition Support Center Chemical and Biological Defense organization in September 2023, with a potential value of $18.8 million through January...
- This is a firm fixed price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract has a ceiling value of $17,254.06 and an ultimate completion date of April 22, 2024. The contract provides medical supplies, with no set-aside designation. Biofire Defense has received prior federal contracts and grants, including a $6.2 million...
- The U.S. Bureau of Administration awarded a $17,254.06 firm fixed-price purchase order to Biofire Defense LLC for medical supplies. The contract has an ultimate completion date of February 9, 2024 and was not set aside for a specific business type. Biofire Defense is a for-profit limited liability company that manufactures goods for biodefense and infectious disease diagnostics, including the Biofire FilmArray and RAZOR Mk II systems. The company has previously received other prime and...
The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), has awarded a $43,544,163 Firm Fixed Price contract to Biofire Defense LLC to advance the development of the Reveal Rapid Antibiotic Susceptibility Test (AST) System as an diagnostic countermeasure for life-threatening urgent infections. This contract, which runs through December 31, 2026, stems from a Broad Agency Announcement issued by BARDA in 2017 seeking proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear and pandemic influenza threats. Biofire Defense has a history of providing diagnostic products and services to various federal agencies, including the Department of Defense. The contract includes a subcontract to Specific Diagnostics, Inc. to support the extension of the Reveal Rapid AST System. This contract award does not have a set-aside designation.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
SOWNO1ASTS | Specific Diagnostics, Inc. | Definitive Contract 75A50122C00057 | $9.0m | 9/22/22 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Other Administrative Action | $0 | 12/20/24 | |
| P00005 | Other Administrative Action | $0 | 10/25/24 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 6/27/24 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 5/21/24 | |
| P00002 | Supplemental Agreement for work within scope | $1.9m | 8/24/23 |